General Oncology Care in Jordan

Abstract

As Jordanians celebrate the 100th years (1921–2021) anniversary of the state of Jordan, a centenary of achievements and successes of those populations, which is equivalent to 0.13% of the total world inhabitants (Jordan Population, worldometers.info 2021), cancer burden in the Hashemite Kingdom of Jordan is a challenge, as well as a success. Despite several initiatives, Jordan does not have an endorsed National Cancer Control Strategic Plan (NCCP), which is one of the top primacies in the national cancer control issue in Jordan.Cancer care in Jordan is well established and attentive on the treatment section, with more effort needed on other elements of the cancer continuum. Jordan has a national cancer registry. However, it is not enough to collect complete, accurate, and timely cancer data.In Jordan, the government bears the cost of treating cancer patients. Cancer treatment is offered at no cost to all Jordanian citizens holding a national number through public hospitals of the MOH mainly in Al Basheer Hospital. The Royal Medical Services (military), university hospitals, and King Hussein Cancer Center (KHCC) treat the cancer patients with special arrangements of acquittal health exemption from the royal court or the health insurance administration to cover the cost of the treatment. A full spectrum of treatment is available in the private health sector too.The health care system in Jordan is one of the best reputable and trustworthy prominent health care systems in the MENA region, if not, it is globally well known. Wide-ranging oncology care is available in many public and private hospitals and health care facilities and clinics. Jordan will always be open to all its Arab fellows, at the same time open for new and up-to-date innovations, cooperation, and collaboration with cancer scholars.

Systemic Barriers to Optimal Cancer Care in Resource-Limited Countries: Jordanian Healthcare as an Example

“…According to the latest Jordan Cancer Registry report, 10,000 new cancer cases were registered at KHCC in 2019, of which 75.9% were Jordanian citizens, representing substantial national reach [ 2 ]. Over 20% of cancer patients came from neighboring countries, reflecting KHCC’s emergence as a reputable tertiary care destination in the region despite local and regional challenges [ 94 ]. Managing an international population presents unique challenges but also allows experience-sharing with global centers.…”

Constipation Severity and Quality of Life among Patients with Cancer Who Received Prophylactic Laxatives: Quasi-Experimental Study

“…This study was conducted in a single oncology outpatient clinic at the biggest governmental hospital in Jordan, where about 26% of patients with cancer are followed (Khatib and Nimri, 2022).…”

In vitro biological studies and computational prediction-based analyses of pyrazolo[1,5-a]pyrimidine derivatives

“…19 As estimated by cancer statistics in the Arab World, in 2018, cancer was responsible for 16.1% of deaths in Tunisia, 20 while in 2016, it was responsible for 16.2% of deaths in Jordan. 21 Cancer treatment and care match the global trend, and cancer research is increasing in the Arab world. 22,23 The therapy strategy for cancer depends on the organ affected, the rate of spread, and the patient's health state.…”